who should not take glp 1 receptor agonists Your guide to GLP-1 side effects How should GLP-1 receptor agonists
Description
Broeders M, Velseboer DC, de Bie R, Speelman JD, Muslimovic D, Post B, et al
In a study assessing all 3 bariatric surgeries, ICP was significantly decreased for individuals with IIH, and there was a significant improvement in quality of life
Due to DPP-4 and renal clearance, native GLP-1 in humans has a half-life of about 1-2 minutes (89)
Interestingly, research on vildagliptin indicates that DPP4 inhibition may also improve insulin sensitivity in type 2 diabetes, as shown through indirect assessments of insulin sensitivity [52] and the hyperinsulinemic euglycemic clamp test [60]
